[Features of sepsis in children today] NLM AIDSLINE Important note: Information in this article was accurate in 1982. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Features of sepsis in children today]

Arkh Patol. 1982;44(3):48-53. Unique Identifier : AIDSLINE MED/82205464
Ivanovskaia TE; Kiparisova EL

Abstract: High risk groups of infants with regard to sepsis are described. The first high risk group includes newborn babies, infants of the first 3 months of age, premature babies, the second babies with congenital defects of the immune system (classified and unclassified defects), the third babies with acquired immune deficiency conditions due predominantly to the pathology of therapy. Septicemia remains the main clinico-anatomical form of sepsis in infants. The morphological criteria of this form of sepsis are described. In the lack of decrease of sepsis incidence in infants pathology of a therapy plays a great role, but it should be remembered that sepsis nowadays is observed in babies who previously had died within a short period of time after birth or after the onset of the disease.
Keywords: Bacterial Infections/*PATHOLOGY Catheterization Disseminated Intravascular Coagulation/ETIOLOGY English Abstract Erythroblastosis, Fetal/COMPLICATIONS Female Human Immunologic Deficiency Syndromes/*CONGENITAL Infant Infant, Newborn Infant, Premature, Diseases/PATHOLOGY Mycoses/*PATHOLOGY Pregnancy Risk Septicemia/*PATHOLOGY Subclavian Vein Umbilical Veins JOURNAL ARTICLE

KWDbacterialinfections/KWDpathologycatheterizationdisseminatedintravascularcoagulation/etiologyenglishabstracterythroblastosis,fetal/complicationsfemalehumanimmunologicdeficiencysyndromes/KWDcongenitalinfantinfant,newborninfant,premature,diseases/pathologymycoses/KWDpathologypregnancyrisksepticemia/KWDpathologysubclavianveinumbilicalveinsjournalarticle
820930
M8290014

Copyright © 1982 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1982. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1982. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .